YU41093A - Terapeutska triazinska jedinjenja i njihova primena - Google Patents

Terapeutska triazinska jedinjenja i njihova primena

Info

Publication number
YU41093A
YU41093A YU41093A YU41093A YU41093A YU 41093 A YU41093 A YU 41093A YU 41093 A YU41093 A YU 41093A YU 41093 A YU41093 A YU 41093A YU 41093 A YU41093 A YU 41093A
Authority
YU
Yugoslavia
Prior art keywords
pct
therapyutic
therapyline
compounds
applications
Prior art date
Application number
YU41093A
Other languages
English (en)
Other versions
YU48573B (sh
Inventor
Craig Meirr Nakamura
Original Assignee
The Wellcome Foundation Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929212495A external-priority patent/GB9212495D0/en
Priority claimed from GB939308654A external-priority patent/GB9308654D0/en
Application filed by The Wellcome Foundation Ltd. filed Critical The Wellcome Foundation Ltd.
Publication of YU41093A publication Critical patent/YU41093A/sh
Publication of YU48573B publication Critical patent/YU48573B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

TERAPEUTSKA TRIAZINSKA JEDINJENJA I NJIHOVA PRIMENA, 3,54liamino-6-(2,3-dihlorfenil)-l,2,4-triazin i njegove farmaceutski i veterinarski prihvatljive soli ispoljavaju aktivnost u (A) sprečavanju ili redukovanju zavisnosti i (B) sprečavanju ili redukovanju tolerancije ili reversne tolerancije prema nekom agensu koji indukuje zavisnost kao što je to neki opioid, depresant centralnog nervnog sistema, psihostimulator ili nikotin.
YU41093A 1992-06-12 1993-06-11 Upotreba 3,5-diamino-6-(2,3-dihlorofenil)-1,2,4-triazin izetionata kao sredstva protiv zavisnosti, tolerancije i osetljivosti na lekove YU48573B (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929212495A GB9212495D0 (sh) 1992-06-12 1992-06-12
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use

Publications (2)

Publication Number Publication Date
YU41093A true YU41093A (sh) 1996-10-09
YU48573B YU48573B (sh) 1998-12-23

Family

ID=26301060

Family Applications (1)

Application Number Title Priority Date Filing Date
YU41093A YU48573B (sh) 1992-06-12 1993-06-11 Upotreba 3,5-diamino-6-(2,3-dihlorofenil)-1,2,4-triazin izetionata kao sredstva protiv zavisnosti, tolerancije i osetljivosti na lekove

Country Status (23)

Country Link
US (1) US5801171A (sh)
EP (1) EP0644763B1 (sh)
JP (1) JP3439211B2 (sh)
KR (1) KR100268823B1 (sh)
AT (1) ATE147980T1 (sh)
AU (1) AU688729B2 (sh)
CA (1) CA2137782A1 (sh)
CZ (1) CZ284061B6 (sh)
DE (1) DE69307705T2 (sh)
DK (1) DK0644763T3 (sh)
ES (1) ES2097516T3 (sh)
GB (1) GB2282326A (sh)
GR (1) GR3022671T3 (sh)
HR (1) HRP930964B1 (sh)
IL (1) IL105986A (sh)
MY (1) MY109330A (sh)
NO (1) NO306451B1 (sh)
NZ (1) NZ253260A (sh)
SI (1) SI9300318A (sh)
SK (1) SK279730B6 (sh)
TW (1) TW284689B (sh)
WO (1) WO1993025207A1 (sh)
YU (1) YU48573B (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059987B1 (en) * 1979-06-01 1985-08-14 The Wellcome Foundation Limited Alpha-cyano-alpha-((n-guanidino)-imino) toluenes
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
GB2282326A (en) 1995-04-05
DE69307705D1 (de) 1997-03-06
DE69307705T2 (de) 1997-05-22
DK0644763T3 (da) 1997-07-28
MY109330A (en) 1997-01-31
GB9423697D0 (en) 1995-01-11
TW284689B (sh) 1996-09-01
HRP930964A2 (en) 1996-02-29
JP3439211B2 (ja) 2003-08-25
AU688729B2 (en) 1998-03-19
KR950701814A (ko) 1995-05-17
EP0644763B1 (en) 1997-01-22
SK279730B6 (sk) 1999-02-11
IL105986A (en) 1998-12-06
AU4345293A (en) 1994-01-04
GR3022671T3 (en) 1997-05-31
HRP930964B1 (en) 2000-06-30
NZ253260A (en) 1997-05-26
CZ284061B6 (cs) 1998-08-12
SI9300318A (en) 1994-03-31
YU48573B (sh) 1998-12-23
ATE147980T1 (de) 1997-02-15
WO1993025207A1 (en) 1993-12-23
EP0644763A1 (en) 1995-03-29
CA2137782A1 (en) 1993-12-23
IL105986A0 (en) 1993-10-20
NO944790D0 (no) 1994-12-09
NO306451B1 (no) 1999-11-08
US5801171A (en) 1998-09-01
JPH07507790A (ja) 1995-08-31
KR100268823B1 (ko) 2000-12-01
CZ312894A3 (en) 1995-07-12
ES2097516T3 (es) 1997-04-01
SK153494A3 (en) 1996-01-10
NO944790L (no) 1994-12-09

Similar Documents

Publication Publication Date Title
GR3029568T3 (en) Pyrazoles and pyrazolopyrimidines having crf antagonist activity.
MY103536A (en) New use of 5 ht-3 antagonists
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
AU5871694A (en) Combination for treating hiv infections containing thymosine, interleukin and hiv replication or reverse transcriptase inhibitors
YU41093A (sh) Terapeutska triazinska jedinjenja i njihova primena
TW226331B (sh)
AU8090591A (en) Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
TR199900774T2 (xx) HIV enfeksiyonu ile ilgili merkezi sinir sistemi hastal�klar�n�n tedavisi i�in bir ilac�n yap�m�nda PKC inhibit�rlerinin kullan�m�.